Suven Life Sciences Allots 2,71,970 Equity Shares Following ESOP Exercise
Suven Life Sciences Limited announced the allotment of 2,71,970 equity shares to eligible employees upon the exercise of vested options under the Suven Life Sciences Limited Employee Stock Option Scheme 2020 (SLSL ESOP 2020). The decision was approved by the Nomination & Remuneration Committee during a meeting held on June 22, 2026.The allotment is related to the exercise of options under the SLSL ESOP 2020 Scheme. The issue details indicate that the equity shares were issued at an exercise price of Rs. 55/- each. This pricing includes a premium of Rs. 54/- per share, with the par value set at Rs.1/- per share.
The total money realized from the exercise of options for this current allotment stood at Rs. 1,49,58,350/-.
Capital Structure Update
Following the issuance of these shares, the company's paid-up equity share capital has been updated as detailed below:| Particulars | No. of Equity Shares | Amount in INR |
|---|---|---|
| Pre-issue subscribed & paid-up capital | 26,37,20,583 | 26,37,20,583.00 |
| Post-issue subscribed and paid-up capital | 26,39,92,553 | 26,39,92,553.00 |
The issued shares rank pari passu with existing shares. According to the details provided under the SLSL ESOP 2020 Scheme, these options were exercised in the current allotment, resulting in 2,71,970 equity shares being generated. The total number of shares arising from this exercise is 2,71,970.
Details regarding the company's registered office and listing on BSE Limited and National Stock Exchange of India Limited were provided along with the issuance details for the Equity Shares.
SUVEN Stock Price Movement
Shares of Suven Life Sciences Limited today slipped by 1.81% to settle at ₹268.2, shedding ₹4.85 in the post-market trading session. The stock saw a total traded volume of roughly 1.54 million shares.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.